Moroi Morgan K, Vinogradsky Alice V, Nguyen Stephanie N, Choudhury Tarif A, Krishnamurthy Ganga, Kalfa David, Bacha Emile A, Levasseur Stéphanie, Goldstone Andrew B
Section of Pediatric and Congenital Cardiac Surgery, Department of Surgery, NewYork Presbyterian-Morgan Stanley Children's Hospital, New York, NY.
Division of Pediatric Critical Care Medicine, Department of Pediatrics, NewYork Presbyterian-Morgan Stanley Children's Hospital, New York, NY; Division of Cardiology, Department of Pediatrics, NewYork Presbyterian-Morgan Stanley Children's Hospital, New York, NY.
J Thorac Cardiovasc Surg. 2025 Mar;169(3):999-1011.e13. doi: 10.1016/j.jtcvs.2024.09.046. Epub 2024 Oct 3.
Surgeons may leave a residual atrial-level communication during complete repair of tetralogy of Fallot (TOF) in anticipation of restrictive right ventricle physiology or as routine practice. We investigated the impact of closing the interatrial communication at the time of definitive TOF repair.
We retrospectively reviewed TOF patients who underwent definitive repair at age <12 months between June 2000 and January 2023. Propensity score matching identified 82 patients with a patent interatrial communication and 50 patients with no interatrial communication on postoperative echocardiography (as-treated analysis). The primary endpoint was maximum vasoactive-inotropic score (VIS) as a surrogate for low cardiac output syndrome.
A total of 132 patients (median age, 3.5 months; interquartile range [IQR], 1.8-5.8 months) were matched. There was no difference in maximum VIS (patent interatrial communication: 5.0 [IQR, 4.8-9.0] vs no interatrial communication: 6.0 [IQR, 5.0-8.0]; P = .78). Additionally, the duration of inotrope therapy (3.0 [IQR, 2.0-4.0] days vs 3.0 [IQR, 1.3-4.0] days; P = .57), peak lactate (2.2 [IQR, 1.9-3.0] mmol/L vs 2.3 [IQR, 1.9-3.2] mmol/L; P = .58), time to lactate clearance (0.2 [IQR, 0.0-0.3] days vs 0.1 [IQR, 0.0-0.3] days; P = .57), chest tube duration (4.0 [IQR, 3.0-6.0] days vs 4.0 [IQR, 3.0-5.0] days; P = .23), and length of intensive care unit stay (5.0 [IQR, 3.0-7.0] days vs 5.0 [IQR, 3.0-7.0] days; P = .71) were similar in the 2 groups. The median duration of follow-up was 5.5 years (IQR, 2.7-9.9 years). Among patients with a residual communication, patency rates were 93.6% at discharge and 53.7% at latest follow-up, with most having bidirectional shunting across the defect.
Closure of the atrial-level communication during complete TOF repair does not significantly impact the immediate postoperative course or mid-term outcomes. Further investigation is warranted to better understand how patency influences long-term outcomes.
在法洛四联症(TOF)的完全修复过程中,外科医生可能会因预期右心室生理功能受限或作为常规操作而留下残余的心房水平交通。我们研究了在TOF确定性修复时关闭心房交通的影响。
我们回顾性分析了2000年6月至2023年1月期间年龄小于12个月接受确定性修复的TOF患者。倾向评分匹配确定了82例术后超声心动图显示有心房交通开放的患者和50例无心房交通的患者(实际治疗分析)。主要终点是最大血管活性药物-正性肌力药物评分(VIS),作为低心输出量综合征的替代指标。
共匹配了132例患者(中位年龄3.5个月;四分位间距[IQR],1.8 - 5.8个月)。最大VIS无差异(心房交通开放:5.0[IQR,4.8 - 9.0] vs 无心房交通:6.0[IQR,5.0 - 8.0];P = 0.78)。此外,两组间正性肌力药物治疗持续时间(3.0[IQR,2.0 - 4.0]天 vs 3.0[IQR,1.3 - 4.0]天;P = 0.57)、乳酸峰值(2.2[IQR,1.9 - 3.0] mmol/L vs 2.3[IQR,1.9 - 3.2] mmol/L;P = 0.58)、乳酸清除时间(0.2[IQR,0.0 - 0.3]天 vs 0.1[IQR,0.0 - 0.3]天;P = 0.57)、胸管留置时间(4.0[IQR,3.0 - 6.0]天 vs 4.0[IQR,3.0 - 5.0]天;P = 0.23)以及重症监护病房住院时间(5.0[IQR,3.0 - 7.0]天 vs 5.0[IQR,3.0 - 7.0]天;P = 0.71)相似。中位随访时间为5.5年(IQR,2.7 - 9.9年)。在有残余交通的患者中,出院时通畅率为93.6%,最近一次随访时为53.7%,大多数存在跨缺损的双向分流。
在TOF完全修复过程中关闭心房水平交通对术后即刻病程或中期结局无显著影响。有必要进一步研究以更好地了解通畅情况如何影响长期结局。